NHC SEC Filing News — National HealthCare Corporation

Latest SEC filings for National HealthCare Corporation (NHC) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-09-23.

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. It operates through two segments: Inpatient and Homecare and Hospice Services. The company's skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and reha…
Sector: Healthcare Industry: Medical Care Facilities Market Cap: $3.7B
20
Total Filings
1
Bullish Classifications
8
Bearish Classifications
14
Insider Transactions
4
Material Events (8-K)
1
Periodic Reports
Rule-based classifications for NHC currently lean bearish. Of the 20 filing records displayed, 8 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 1 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
NHC Filing Activity Snapshot 2026-05-27 — 2026-09-23
Insider Transactions (Form 4)
1 buy vs 8 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$1.59M
FLATT BEN ANDERSON SR (Senior VP & CIO) · 2026-09-02
7,000 shares · Form 4
Form 144 Notices
1
Proposed insider sale filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 14 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 14 filings in this group are Form 4s for National HealthCare Corporation.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 14 insider filings shown, the breakdown is 8 open-market sale, 3 option exercise, 1 compensation award, 1 gift and 1 open-market purchase. 9 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×8
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Option exercise ×3
The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.
Compensation award ×1
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Gift ×1
Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.
Open-market purchase ×1
The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.
Form 4 Open-market sale Insider Selling 2026-09-23

NHC insider Dodson Vicki L (Sr.VP Patient Srvcs) sold 4,834 shares (~$1.09M)

Dodson Vicki L, listed as Sr.VP Patient Srvcs at NATIONAL HEALTHCARE CORP, reported an open-market sale of 4,834 NHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 4,834 $225.00 $1.09M
Filing: Form 4 (Insider Transaction) Insider: Dodson Vicki L (Sr.VP Patient Srvcs) Shares: 4,834 Est. Value: $1.09M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-14

NHC insider McCreary Josh A (Senior VP & General Counsel) sold 2,719 shares (~$609.7K)

McCreary Josh A, listed as Senior VP & General Counsel at NATIONAL HEALTHCARE CORP, reported an open-market sale of 2,719 NHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 571 $222.73 $127.2K
S Open-market sale 789 $223.78 $176.6K
S Open-market sale 1,291 $225.09 $290.6K
S Open-market sale 68 $225.59 $15.3K
Filing: Form 4 (Insider Transaction) Insider: McCreary Josh A (Senior VP & General Counsel) Shares: 2,719 Est. Value: $609.7K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-14

NHC insider KIDD BRIAN F (SVP, CFO) sold 6,813 shares (~$1.54M)

KIDD BRIAN F, listed as SVP, CFO at NATIONAL HEALTHCARE CORP, reported an open-market sale of 6,813 NHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 6,813 $225.70 $1.54M
Filing: Form 4 (Insider Transaction) Insider: KIDD BRIAN F (SVP, CFO) Shares: 6,813 Est. Value: $1.54M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-02

NHC insider FLATT BEN ANDERSON SR (Senior VP & CIO) sold 7,000 shares (~$1.59M)

FLATT BEN ANDERSON SR, listed as Senior VP & CIO at NATIONAL HEALTHCARE CORP, reported an open-market sale of 7,000 NHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 1,000 $221.21 $221.2K
S Open-market sale 1,000 $222.11 $222.1K
S Open-market sale 1,000 $226.00 $226.0K
S Open-market sale 1,000 $237.18 $237.2K
S Open-market sale 1,000 $237.00 $237.0K
S Open-market sale 1,000 $227.00 $227.0K
S Open-market sale 1,000 $222.50 $222.5K
Filing: Form 4 (Insider Transaction) Insider: FLATT BEN ANDERSON SR (Senior VP & CIO) Shares: 7,000 Est. Value: $1.59M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-28

NHC insider Gifford David R. (Director) sold 1,779 shares (~$401.0K)

Gifford David R., listed as Director at NATIONAL HEALTHCARE CORP, reported an open-market sale of 1,779 NHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 1,779 $225.42 $401.0K
Filing: Form 4 (Insider Transaction) Insider: Gifford David R. (Director) Shares: 1,779 Est. Value: $401.0K
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-21

NHC insider Form 4 filed for equity award, exercise, or tax withholding

Gifford David R. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 6,479 $171.42 $1.11M
A Compensation award 4,691 $236.75 $1.11M
M Option exercise derivative · Option to Purchase Common Stock [2026 Grant] 6,479 — —
Filing: Form 4 (Insider Transaction) Insider: Gifford David R. (Director) Shares: 11,170
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-20

NHC insider Flatt Stephen Fowler (Director, CEO) sold 1,500 shares (~$355.6K)

Flatt Stephen Fowler, listed as Director, CEO at NATIONAL HEALTHCARE CORP, reported an open-market sale of 1,500 NHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 1,500 $237.08 $355.6K
Filing: Form 4 (Insider Transaction) Insider: Flatt Stephen Fowler (Director, CEO) Shares: 1,500 Est. Value: $355.6K
View on SEC EDGAR → Open Filing Document →
Form 4 Option exercise Tax / Compensation Filing 2026-08-17

NHC insider Form 4 filed for equity award, exercise, or tax withholding

Gifford David R. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 1,021 $171.42 $175.0K
M Option exercise derivative · Option to Purchase Common Stock [2026 Grant] 1,021 — —
Filing: Form 4 (Insider Transaction) Insider: Gifford David R. (Director) Shares: 1,021
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-06-23

NHC insider HASSAN EMIL E (Director) sold 5,937 shares (~$1.19M)

HASSAN EMIL E, listed as Director at NATIONAL HEALTHCARE CORP, reported an open-market sale of 5,937 NHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 5,937 $200.00 $1.19M
Filing: Form 4 (Insider Transaction) Insider: HASSAN EMIL E (Director) Shares: 5,937 Est. Value: $1.19M
View on SEC EDGAR → Open Filing Document →
Form 4 Gift Tax / Compensation Filing 2026-06-18

NHC insider Form 4 filed for equity award, exercise, or tax withholding

KIDD BRIAN F (SVP, CFO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.

Transactions reported on this filing
Code Nature Shares Price Value
G Gift 500 — —
Filing: Form 4 (Insider Transaction) Insider: KIDD BRIAN F (SVP, CFO) Shares: 500
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-06-18

NHC insider HASSAN EMIL E (Director) sold 1,563 shares (~$312.6K)

HASSAN EMIL E, listed as Director at NATIONAL HEALTHCARE CORP, reported an open-market sale of 1,563 NHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 1,563 $199.97 $312.6K
Filing: Form 4 (Insider Transaction) Insider: HASSAN EMIL E (Director) Shares: 1,563 Est. Value: $312.6K
View on SEC EDGAR → Open Filing Document →
Form 4 Option exercise Tax / Compensation Filing 2026-06-10

NHC insider Form 4 filed for equity award, exercise, or tax withholding

ADAMS ROBERT G (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 4,000 $69.19 $276.8K
G Gift 4,000 — —
M Option exercise derivative · Option to Purchase Common Stock [2022 Grant] 4,000 — —
Filing: Form 4 (Insider Transaction) Insider: ADAMS ROBERT G (Director) Shares: 8,000
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market purchase Insider Buying 2026-06-02

NHC insider Piercey Lisa (Director) bought 949 shares (~$174.9K)

Piercey Lisa, listed as Director at NATIONAL HEALTHCARE CORP, reported an open-market purchase of 949 NHC shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code Nature Shares Price Value
P Open-market purchase 949 $184.26 $174.9K
Filing: Form 4 (Insider Transaction) Insider: Piercey Lisa (Director) Shares: 949 Est. Value: $174.9K
View on SEC EDGAR → Open Filing Document →
Form 4 Option exercise Tax / Compensation Filing 2026-05-27

NHC insider Form 4 filed for equity award, exercise, or tax withholding

FLATT BEN ANDERSON SR (Senior VP & CIO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 4,000 $94.10 $376.4K
F Tax withholding on vested shares 2,739 $196.00 $536.8K
M Option exercise derivative · Option to Purchase Common Stock 4,000 — —
Filing: Form 4 (Insider Transaction) Insider: FLATT BEN ANDERSON SR (Senior VP & CIO) Shares: 6,739
View on SEC EDGAR → Open Filing Document →
Proposed Insider Sales 1 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. National HealthCare Corporation has 1 such notice in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-09-10

NHC Form 144 filed for proposed insider sale by McCreary Josh A (2,719 shares) ~$600.8K

McCreary Josh A filed a Form 144 with the SEC indicating intent to sell NHC (NATIONAL HEALTHCARE CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: McCreary Josh A Shares: 2,719 Est. Value: $600.8K
View on SEC EDGAR → Open Filing Document →
Material Events 4 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 4 in this period for National HealthCare Corporation. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-08-11

NHC filed 8-K — material company event

NATIONAL HEALTHCARE CORP filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-08-11

NHC filed 8-K — material company event

NATIONAL HEALTHCARE CORP filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-07-01

NHC filed 8-K — material company event

NATIONAL HEALTHCARE CORP filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-05-27

NHC filed 8-K — material company event

NATIONAL HEALTHCARE CORP filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for National HealthCare Corporation.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-06

NHC filed Quarterly Report (10-Q)

NATIONAL HEALTHCARE CORP filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)
View on SEC EDGAR → Open Filing Document →

How we classify National HealthCare Corporation's filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on NHC. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — NHC SEC Filings

More Tools for NHC

NHC Full Stock Analysis NHC Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper NHC analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the NHC stock analysis page.

NHC Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer